Ascendis Pharma (ASND) Reports Q2 EPS by EUR (1.46)

Ascendis Pharma (NASDAQ: ASND) reported Q2 EPS of EUR(1.46).

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• C.H. Robinson acquires DeSpir Logistics for $75 million